DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Continente #
EU - Europa 1.704
AS - Asia 1.656
NA - Nord America 950
SA - Sud America 190
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 4.532
Nazione #
US - Stati Uniti d'America 939
SG - Singapore 664
SE - Svezia 594
HK - Hong Kong 519
CN - Cina 412
IT - Italia 325
RO - Romania 263
RU - Federazione Russa 214
BR - Brasile 178
DE - Germania 95
FI - Finlandia 65
AT - Austria 32
IE - Irlanda 31
NL - Olanda 31
IN - India 12
BE - Belgio 9
IR - Iran 9
TR - Turchia 9
UA - Ucraina 9
AU - Australia 8
ES - Italia 8
GB - Regno Unito 8
EU - Europa 7
CA - Canada 6
FR - Francia 5
PK - Pakistan 5
TH - Thailandia 5
ZA - Sudafrica 5
CO - Colombia 4
IQ - Iraq 4
JP - Giappone 4
MX - Messico 4
BD - Bangladesh 3
MA - Marocco 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
CH - Svizzera 2
EE - Estonia 2
EG - Egitto 2
PL - Polonia 2
PY - Paraguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GR - Grecia 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 4.532
Città #
Hong Kong 514
Shanghai 311
Lawrence 203
Princeton 201
Singapore 192
Ashburn 146
Milan 118
Moscow 68
New York 64
Helsinki 55
Nuremberg 36
Rome 32
Dublin 31
Boardman 26
Bologna 12
Los Angeles 12
São Paulo 12
Vienna 12
Guangzhou 10
Washington 10
Dallas 9
Pune 9
Shenzhen 9
Amsterdam 8
West Jordan 8
Genoa 7
Seattle 7
Borås 6
Cassina de' Pecchi 6
Jiaxing 6
Meppel 6
Santa Clara 6
Belo Horizonte 5
Brussels 5
Espoo 5
Falkenstein 5
Lappeenranta 5
Sydney 5
Bangkok 4
Beijing 4
Bitetto 4
Reston 4
Abbotsford 3
Brasília 3
Canberra 3
Canegrate 3
Caserta 3
Chicago 3
Council Bluffs 3
Curitiba 3
Ferrara 3
Gatchina 3
Hanover 3
Knaresborough 3
Lahore 3
Naples 3
Oshnaviyeh 3
Romagnano Sesia 3
São José do Rio Preto 3
Tashkent 3
Tokyo 3
Vicenza 3
Andover 2
Aprilia 2
Araçatuba 2
Bari 2
Belém 2
Bergamo 2
Berlin 2
Betim 2
Beveren 2
Blumenau 2
Bolzano 2
Botucatu 2
Campinas 2
Cape Town 2
Castenaso 2
Cesano Boscone 2
Corbera de Llobregat 2
Esparreguera 2
Florianópolis 2
Fortaleza 2
Francavilla al Mare 2
Frankfurt am Main 2
Fuzhou 2
Gilbert 2
Glasgow 2
Goiânia 2
Guarulhos 2
Hangzhou 2
Istanbul 2
Jena 2
Johannesburg 2
Karachi 2
Kish 2
Lissone 2
Livorno 2
Lorena 2
Medellín 2
Mestre 2
Totale 2.334
Nome #
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 288
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 111
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 88
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 72
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 65
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 48
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 44
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 42
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 41
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 40
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 37
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 36
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 36
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 35
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 34
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 34
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 33
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 33
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 32
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 32
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 32
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy 31
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 30
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 30
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 30
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 30
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 29
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 28
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 27
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 27
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 27
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 26
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 26
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 26
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers 25
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 25
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 25
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 25
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 25
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 24
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 24
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 24
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 24
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 24
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 24
Oligometastatic disease in prostate cancer, a continuously changing paradigm: Patient selection and treatment strategy 24
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 24
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy: Impact of time between surgery and radiotherapy 23
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 23
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 23
Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71;37–43: High-dose Radiotherapy and Pelvic Lymph Nodal Irradiation for High-risk Prostate Cancer in the Image-guided Radiotherapy Era 23
Quality indicators in the intensity modulated/image-guided radiotherapy era 23
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 23
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 23
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 23
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients 22
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 22
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 22
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 22
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 22
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 22
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 22
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 21
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review 21
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 21
Skin Dose Variations during Tomotherapy for Head and Neck Cancer Patients: Need for Adaptive Replanning? 21
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 20
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients 20
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis 20
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 20
Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy 20
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 20
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 20
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 20
Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study 20
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 20
Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy 20
Clinical implementation of low-dose total body irradiation using topotherapy technique 20
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study 20
Virtual Tangential-fields Arc Therapy (ViTAT) for whole breast irradiation: Technique optimization and validation 20
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 19
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience 19
IL GLEASON SCORE PATOLOGICO INFLUENZA FORTEMENTE LA SOPRAVVIVENZA IN PAZIENTI CON INVASIONE DELLE VESCICOLE SEMINALI SOTTOPOSTI A PROSTATECTOMIA RADICALE E RADIOTERAPIA ADIUVANTE 19
PET/CT for radiotherapy: image acquisition and data processing 19
Segmentation of FDG PET lung lesions based on a thresholding approach for BTV definition 19
Analysis of serial CT images for studying the RT effects in head-neck cancer patients 19
Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation 19
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 19
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 19
Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer 19
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 19
Reply to Salvador Vale's Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44–5. Preclinical Combinatory Approach to Enhance Radiotherapy Effects and Reduce its Morbidity may be Tested in the Clinic: Wider Whole-pelvis Radiotherapy Fields and Enhanced Antitumoral Effect Mediated by T Lymphocytes: A Legitimate Hypothesis? 19
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design 19
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 19
SOPRAVVIVENZA CANCRO-SPECIFICA DEI PAZIENTI CON RIPRESA BIOCHIMICA DI MALATTIA DOPO PROSTATECTOMIA RADICALE E RADIOTERAPIA ADIUVANTE PER TUMORE PROSTATICO LOCALMENTE AVANZATO 18
Salvage radiation therapy after prostatectomy: Understanding the dose–response effect 18
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 18
Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC 18
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies 18
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 18
Totale 2.973
Categoria #
all - tutte 62.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 3 1 1
2020/202182 0 0 0 15 0 50 6 1 0 0 1 9
2021/2022145 0 0 2 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024675 11 35 59 127 46 113 22 54 18 42 53 95
2024/20252.690 431 72 53 117 105 247 680 200 548 237 0 0
Totale 4.811